Stock Analysis: Raffles Medical Group | Lianhe Zaobao
I'm PortAI, I can summarize articles.
Raffles Medical Group recommends buying, with a target price of SGD 1.32 and a closing price of SGD 0.995 (+1.01%). The group is a comprehensive private healthcare service provider, primarily operating in Singapore and has expanded to China. The new Chief Financial Officer Woo Yeng Yeng has 20 years of experience, and her appointment will drive strategic initiatives and profitability in China. Maintain buy rating, as the stock price is supported by share buybacks and stable business
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zaobao The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments